An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine

被引:90
作者
Hooker, DJ
Tachedjian, G
Solomon, AE
Gurusinghe, AD
Land, S
Birch, C
Anderson, JL
Roy, BM
Arnold, E
Deacon, NJ
机构
[1] MACFARLANE BURNET CTR MED RES,AIDS MOL BIOL LAB,FAIRFIELD,VIC 3078,AUSTRALIA
[2] MACFARLANE BURNET CTR MED RES,ANTIVIRAL RES LAB,FAIRFIELD,VIC 3078,AUSTRALIA
[3] MACFARLANE BURNET CTR MED RES,NATL CTR HIV VIROL RES,FAIRFIELD,VIC 3078,AUSTRALIA
[4] FAIRFIELD HOSP,VICTORIAN INFECT DIS REFERENCE LAB,STATE HIV ISOLAT LAB,FAIRFIELD,VIC 3078,AUSTRALIA
[5] RUTGERS STATE UNIV,CTR ADV BIOTECHNOL & MED,PISCATAWAY,NJ 08854
[6] RUTGERS STATE UNIV,DEPT CHEM,PISCATAWAY,NJ 08854
关键词
D O I
10.1128/JVI.70.11.8010-8018.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Sequencing of the reverse transcription (RT) region of 26 human immunodeficiency virus type (HIV-1) isolates from eight patients treated with 3'-azido-3'-deoxythymidine (AZT) revealed a mutation at codon 210 from TTG (leucine) to TGG (tryptophan) exclusively in association with resistance to AZT. The mutation Trp-210 was observed in 15 of the 20 isolates phenotypically resistant to AZT, being more commonly observed than resistance-associated mutations at codons 67, 70, and 219. Trp-210 was never observed before the emergence of resistance-associated mutations Leu-41 and Tyr-215, and in a sequential series of five isolates from one patient the order of emergence of mutations was found to be Tyr-215, Leu-41, and then Trp-210. Trp-210 was also found in association with the Leu-41, Asn-67, Arg-70, and Tyr-215 resistance genotype. To define the role of Trp-210 in AZT resistance, molecular HIV-1 clones were constructed with various combinations of RT mutations at codons 41, 67, 70, 210, and 215 and tested for susceptibility to AZT. In clones with polymerase genes derived either from HXB2-D or clinical isolates, Trp-210 alone did not increase AZT resistance, whereas in conjunction with Leu-41 and Tyr-215, Trp-210 into the genetic context of mutations at codons 41, 67, 70, and 215 further enhanced resistance from a 50% inhibitory concentration of 1.44 mu M to 8.41 mu M. Molecular modeling of the tertiary structure of HIV-1 RT revealed that the distance between the side chains of Trp-210 (in helix alpha F) and Tyr-215 (in strand beta 11a) approximated 4 Angstrom (1 Angstrom = 0.1 nm), sufficiently close to result in significant energetic interaction between these two aromatic side chains. In conclusion, Trp-210 contributes significantly to phenotypic AZT resistance of HIV-1 by augmenting resistance at least three- to sixfold in the context of two resistant genotypes, and its effect may require an interaction with an aromatic amino acid at position 215.
引用
收藏
页码:8010 / 8018
页数:9
相关论文
共 60 条
[1]   IMPROVEMENT OF PCR AMPLIFIED DNA SEQUENCING WITH THE AID OF DETERGENTS [J].
BACHMANN, B ;
LUKE, W ;
HUNSMANN, G .
NUCLEIC ACIDS RESEARCH, 1990, 18 (05) :1309-1309
[2]   ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS [J].
BOUCHER, CAB ;
OSULLIVAN, E ;
MULDER, JW ;
RAMAUTARSING, C ;
KELLAM, P ;
DARBY, G ;
LANGE, JMA ;
GOUDSMIT, J ;
LARDER, BA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :105-110
[3]   SENSITIVITY OF WILD-TYPE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE TO DIDEOXYNUCLEOTIDES DEPENDS ON TEMPLATE LENGTH - THE SENSITIVITY OF DRUG-RESISTANT MUTANTS DOES NOT [J].
BOYER, PL ;
TANTILLO, C ;
JACOBOMOLINA, A ;
NANNI, RG ;
DING, JP ;
ARNOLD, E ;
HUGHES, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4882-4886
[4]   2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (D4T) IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX - A PHASE-I TRIAL [J].
BROWNE, MJ ;
MAYER, KH ;
CHAFEE, SBD ;
DUDLEY, MN ;
POSNER, MR ;
STEINBERG, SM ;
GRAHAM, KK ;
GELETKO, SM ;
ZINNER, SH ;
DENMAN, SL ;
DUNKLE, LM ;
KAUL, S ;
MCLAREN, C ;
SKOWRON, G ;
KOUTTAB, NM ;
KENNEDY, TA ;
WEITBERG, AB ;
CURT, GA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :21-29
[5]   POL MUTATIONS CONFERRING ZIDOVUDINE AND DIDANOSINE RESISTANCE WITH DIFFERENT EFFECTS IN-VITRO YIELD MULTIPLY RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES IN-VIVO [J].
ERON, JJ ;
CHOW, YK ;
CALIENDO, AM ;
VIDELER, J ;
DEVORE, KM ;
COOLEY, TP ;
LIEBMAN, HA ;
KAPLAN, JC ;
HIRSCH, MS ;
DAQUILA, RT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) :1480-1487
[6]  
FISCHL MA, 1989, JAMA-J AM MED ASSOC, V262, P2405
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL GENE-MUTATIONS WHICH CAUSE DECREASED SUSCEPTIBILITY TO 2',3'-DIDEOXYCYTIDINE [J].
FITZGIBBON, JE ;
HOWELL, RM ;
HABERZETTL, CA ;
SPERBER, SJ ;
GOCKE, DJ ;
DUBIN, DT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :153-157
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL GENE-MUTATIONS IN AN AIDS PATIENT TREATED WITH MULTIPLE ANTIRETROVIRAL DRUGS [J].
FITZGIBBON, JE ;
FARNHAM, AE ;
SPERBER, SJ ;
KIM, H ;
DUBIN, DT .
JOURNAL OF VIROLOGY, 1993, 67 (12) :7271-7275
[9]   PHOSPHORYLATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND SELECTIVE INTERACTION OF THE 5'-TRIPHOSPHATE WITH HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE [J].
FURMAN, PA ;
FYFE, JA ;
STCLAIR, MH ;
WEINHOLD, K ;
RIDEOUT, JL ;
FREEMAN, GA ;
LEHRMAN, SN ;
BOLOGNESI, DP ;
BRODER, S ;
MITSUYA, H ;
BARRY, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8333-8337
[10]   INVITRO SELECTION OF VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE [J].
GAO, Q ;
GU, ZX ;
PARNIAK, MA ;
LI, XG ;
WAINBERG, MA .
JOURNAL OF VIROLOGY, 1992, 66 (01) :12-19